Dokumendiregister | Terviseamet |
Viit | 11.1-2/24/3908-1 |
Registreeritud | 10.04.2024 |
Sünkroonitud | 11.04.2024 |
Liik | Sissetulev dokument |
Funktsioon | 11.1 Turustamise järgne järelevalve (post-marketing surveillance) |
Sari | 11.1-2 Kirjavahetus Eesti turule lastavatest/kasutusele võetavatest/levitatavatest seadmetest MSA kaudu teavitamiseks |
Toimik | 11.1-2/2024 |
Juurdepääsupiirang | Avalik |
Juurdepääsupiirang | |
Adressaat | Haleon |
Saabumis/saatmisviis | Haleon |
Vastutaja | Karl Kalev Türk (TA, Peadirektori asetäitja (1) vastutusvaldkond, Meditsiiniseadmete osakond) |
Originaal | Ava uues aknas |
From: Daiva Gustainiene - EW <[email protected]>
Sent: Wed, 10 Apr 2024 12:22:44 +0000
To: "[email protected]" <[email protected]>
Subject: Access to Estonian Medical Device Database for Lithuanian citizen
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. |
Dear Sirs,
I would like to notify Health Board about the first distribution of Class II medical device in Estonian republic, and I need access to EMDDB.
I am citizen of Lithuanian Republic, and most probably manual sign-in with e-mail address and password needs to be created.
Would you mind please to create an account for me (or kindly advise how I can do this myself).
I am ready to provide additional data about myself, if necessary.
Thank you already in advance,
With best regards
Daiva Gustainiene
Regulatory Affairs Manager Baltics
Haleon (former GSK Consumer Healthcare company)
On behalf of Haleon (former GSK company)
Entafarma Plius, Klonėnų vs. 1, Klonėnų vs., Širvintų r., Lithuania
Email [email protected]
Mobile +370 655 41830
The Haleon group monitors email communications sent to and from the Haleon group in order to protect Haleon, our employees, customers, suppliers and business partners, from cyber threats and loss of Haleon group information. Haleon group monitoring is conducted with appropriate confidentiality controls and in accordance with local laws and after appropriate consultation.
Nimi | K.p. | Δ | Viit | Tüüp | Org | Osapooled |
---|---|---|---|---|---|---|
Vastuskiri | 10.04.2024 | 1 | 11.1-2/24/3908-2 🔒 | Väljaminev dokument | ta | Haleon |